Atlas Trials

A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV

Clinical trial NCT02495246 · COMPLETED

Trial details

NCT number
NCT02495246
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ebola Virus Disease
Start date
2015-09-21
Primary completion
2017-08-22
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.